Variability in individual responsiveness to aspirin: clinical implications and treatment.

@article{ComaCanella2007VariabilityII,
  title={Variability in individual responsiveness to aspirin: clinical implications and treatment.},
  author={Isabel Coma-Canella and Amelia Velasc},
  journal={Cardiovascular & hematological disorders drug targets},
  year={2007},
  volume={7 4},
  pages={
          274-87
        }
}
Aspirin protects from cardiovascular events because of its antiaggregant effect. The occurrence of new events in patients who take aspirin has been called clinical aspirin resistance. Many authors believe that aspirin resistance must be detected by biochemical tests, although there is no agreement on which is the best. Nor is there agreement on the term aspirin resistance. Tests used in research laboratories are aggregometry (turbidometric and impedance), tests based on activation-dependent… CONTINUE READING